Influence of molecular genetics in Vogt-Koyanagi-Harada disease

详细信息    查看全文

• 作者：Joanne YW Ng (1)
  Fiona OJ Luk (1)
  Timothy YY Lai (1)
  Chi-Pui Pang (1)
  
  1. Department of Ophthalmology and Visual Sciences ; The Chinese University of Hong Kong ; 3/F Hong Kong Eye Hospital ; 147K Argyle Street ; Kowloon ; 釁? Hong Kong
  
• 关键词：Vogt ; Koyanagi ; Harada disease ; Genetics ; Human leukocyte antigen ; Single ; nucleotide polymorphisms ; Interleukins
• 刊名：Journal of Ophthalmic Inflammation and Infection
• 出版年：2014
• 出版时间：December 2014
• 年：2014
• 卷：4
• 期：1
• 全文大小：368 KB
• 参考文献：1. Yamaki, K, Gocho, K, Hayakawa, K, Kondo, I, Sakuragi, S (2000) Tyrosinase family proteins are antigens specific to Vogt-Koyanagi-Harada disease. J Immunol 165: pp. 7323-7329
  2. Read, RW, Holland, GN, Rao, NA, Tabbara, KF, Ohno, S, Arellanes-Garcia, L, Pivetti-Pezzi, P, Tessler, HH, Usui, M (2001) Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 131: pp. 647-652
  3. Kitamura, M, Takami, K, Kitaichi, N, Namba, K, Kitamei, H, Kotake, S, Ohno, S (2005) Comparative study of two sets of criteria for the diagnosis of Vogt-Koyanagi-Harada's disease. Am J Ophthalmol 139: pp. 1080-1085
  4. Tabbara, KF, Chavis, PS, Freeman, WR (1998) Vogt-Koyanagi-Harada syndrome in children compared to adults. Acta Ophthalmol Scand 76: pp. 723-726
  5. Wang, Y, Chan, CC (2014) Gender differences in Vogt-Koyanagi-Harada disease and sympathetic ophthalmia. J Ophthalmol 2014: pp. 157803
  6. Yang, P, Zhang, Z, Zhou, H, Li, B, Huang, X, Gao, Y, Zhu, L, Ren, Y, Klooster, J, Kijlstra, A (2005) Clinical patterns and characteristics of uveitis in a tertiary center for uveitis in China. Curr Eye Res 30: pp. 943-948
  7. Moorthy, RS, Inomata, H, Rao, NA (1995) Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol 39: pp. 265-292
  8. Yamaki, K, Hara, K, Sakuragi, S (2005) Application of revised diagnostic criteria for Vogt-Koyanagi-Harada disease in Japanese patients. Jpn J Ophthalmol 49: pp. 143-148
  9. Sasamoto, Y, Ohno, S, Matsuda, H (1990) Studies on corticosteroid therapy in Vogt-Koyanagi-Harada disease. Ophthalmologica 201: pp. 162-167
  10. Rubsamen, PE, Gass, JD (1991) Vogt-Koyanagi-Harada syndrome. Clinical course, therapy, and long-term visual outcome. Arch Ophthalmol 109: pp. 682-687
  11. Read, RW, Yu, F, Accorinti, M, Bodaghi, B, Chee, SP, Fardeau, C, Goto, H, Holland, GN, Kawashima, H, Kojima, E, Lehoang, P, Lemaitre, C, Okada, AA, Pivetti-Pezzi, P, Secchi, A, See, RF, Tabbara, KF, Usui, M, Rao, NA (2006) Evaluation of the effect on outcomes of the route of administration of corticosteroids in acute Vogt-Koyanagi-Harada disease. Am J Ophthalmol 142: pp. 119-124
  12. Chee, SP, Luu, CD, Cheng, CL, Lim, WK, Jap, A (2005) Visual function in Vogt-Koyanagi-Harada patients. Graefes Arch Clin Exp Ophthalmol 243: pp. 785-790
  13. Lai, TY, Chan, RP, Chan, CK, Lam, DS (2009) Effects of the duration of initial oral corticosteroid treatment on the recurrence of inflammation in Vogt-Koyanagi-Harada disease. Eye (Lond) 23: pp. 543-548
  14. Rao, NA (2007) Pathology of Vogt-Koyanagi-Harada disease. Int Ophthalmol 27: pp. 81-85
  15. Inomata, H, Rao, NA (2001) Depigmented atrophic lesions in sunset glow fundi of Vogt-Koyanagi-Harada disease. Am J Ophthalmol 131: pp. 607-614
  16. Bassili, SS, Peyman, GA, Gebhardt, BM, Daun, M, Ganiban, GJ, Rifai, A (1996) Detection of Epstein-Barr virus DNA by polymerase chain reaction in the vitreous from a patient with Vogt-Koyanagi-Harada syndrome. Retina 16: pp. 160-161
  17. Sugita, S, Takase, H, Kawaguchi, T, Taguchi, C, Mochizuki, M (2007) Cross-reaction between tyrosinase peptides and cytomegalovirus antigen by T cells from patients with Vogt-Koyanagi-Harada disease. Int Ophthalmol 27: pp. 87-95
  18. Greco, A, Fusconi, M, Gallo, A, Turchetta, R, Marinelli, C, Macri, GF, Virgilio, A, Vincentiis, M (2013) Vogt-Koyanagi-Harada syndrome. Autoimmun Rev 12: pp. 1033-1038
  19. Otani, S, Sakurai, T, Yamamoto, K, Fujita, T, Matsuzaki, Y, Goto, Y, Ando, Y, Suzuki, S, Usui, M, Takeuchi, M, Kawakami, Y (2006) Frequent immune response to a melanocyte specific protein KU-MEL-1 in patients with Vogt-Koyanagi-Harada disease. Br J Ophthalmol 90: pp. 773-777
  20. Klein, J, Sato, A (2000) The HLA system: first of two parts. New Eng J Med 343: pp. 702-709
  21. Shiina, T, Inoko, H, Kulski, JK (2004) An update of the HLA genomic region, locus information and disease associations: 2004. Tissue Antigens 64: pp. 631-649
  22. Stastny, P (1978) Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N Engl J Med 298: pp. 869-871
  23. McMichael, AJ, Sasazuki, T, McDevitt, HO, Payne, RO (1977) Increased frequency of HLA-Cw3 and HLA-Dw4 in rheumatoid arthritis. Arthritis Rheum 20: pp. 1037-1042
  24. Islam, SM, Numaga, J, Fujino, Y, Hirata, R, Matsuki, K, Maeda, H, Masuda, K (1994) HLA class II genes in Vogt-Koyanagi-Harada disease. Invest Ophthalmol Vis Sci 35: pp. 3890-3896
  25. Zhang, XY, Wang, XM, Hu, TS (1992) Profiling human leukocyte antigens in Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol 113: pp. 567-572
  26. Tagawa, Y, Sugiura, S, Yakura, H, Wakisaka, A, Aizawa, M (1976) Letter: HLA and Vogt-Koyanagi-Harada syndrome. N Engl J Med 295: pp. 173
  27. Davis, JL, Mittal, KK, Freidlin, V, Mellow, SR, Optican, DC, Palestine, AG, Nussenblatt, RB (1990) HLA associations and ancestry in Vogt-Koyanagi-Harada disease and sympathetic ophthalmia. Ophthalmology 97: pp. 1137-1142
  28. Shindo, Y, Inoko, H, Yamamoto, T, Ohno, S (1994) HLA-DRB1 typing of Vogt-Koyanagi-Harada's disease by PCR-RFLP and the strong association with DRB1*0405 and DRB1*0410. Br J Ophthalmol 78: pp. 223-226
  29. Shindo, Y, Ohno, S, Yamamoto, T, Nakamura, S, Inoko, H (1994) Complete association of the HLA-DRB1*04 and -DQB1*04 alleles with Vogt-Koyanagi-Harada's disease. Hum Immunol 39: pp. 169-176
  30. Weisz, JM, Holland, GN, Roer, LN, Park, MS, Yuge, AJ, Moorthy, RS, Forster, DJ, Rao, NA, Terasaki, PI (1995) Association between Vogt-Koyanagi-Harada syndrome and HLA-DR1 and -DR4 in Hispanic patients living in southern California. Ophthalmology 102: pp. 1012-1015
  31. Arellanes-Garcia, L, Bautista, N, Mora, P, Ortega-Larrocea, G, Burguet, A, Gorodezky, C (1998) HLA-DR is strongly associated with Vogt-Koyanagi-Harada disease in Mexican Mestizo patients. Ocul Immunol Inflamm 6: pp. 93-100
  32. Levinson, RD, See, RF, Rajalingam, R, Reed, EF, Park, MS, Rao, NA, Holland, GN (2004) HLA-DRB1 and -DQB1 alleles in Mestizo patients with Vogt-Koyanagi-Harada's disease in Southern California. Hum Immunol 65: pp. 1477-1482
  33. Pivetti-Pezzi, P, Accorinti, M, Colabelli-Gisoldi, RA, Pirraglia, MP (1996) Vogt-Koyanagi-Harada disease and HLA type in Italian patients. Am J Ophthalmol 122: pp. 889-891
  34. Goldberg, AC, Yamamoto, JH, Chiarella, JM, Marin, ML, Sibinelli, M, Neufeld, R, Hirata, CE, Olivalves, E, Kalil, J (1998) HLA-DRB1*0405 is the predominant allele in Brazilian patients with Vogt-Koyanagi-Harada disease. Hum Immunol 59: pp. 183-188
  35. Kim, MH, Seong, MC, Kwak, NH, Yoo, JS, Huh, W, Kim, TG, Han, H (2000) Association of HLA with Vogt-Koyanagi-Harada syndrome in Koreans. Am J Ophthalmol 129: pp. 173-177
  36. Iqniebi, A, Gaafar, A, Sheereen, A, Al-Suliman, A, Mohamed, G, Al-Hussein, K, Tabbara, KF (2009) HLA-DRB1 among patients with Vogt-Koyanagi-Harada disease in Saudi Arabia. Mol Vis 15: pp. 1876-1880
  37. Islam, SM, Numaga, J, Matsuki, K, Fujino, Y, Maeda, H, Masuda, K (1994) Influence of HLA-DRB1 gene variation on the clinical course of Vogt-Koyanagi-Harada disease. Invest Ophthalmol Vis Sci 35: pp. 752-756
  38. Damico, FM, Cunha-Neto, E, Goldberg, AC, Iwai, LK, Marin, ML, Hammer, J, Kalil, J, Yamamoto, JH (2005) T-cell recognition and cytokine profile induced by melanocyte epitopes in patients with HLA-DRB1*0405-positive and -negative Vogt-Koyanagi-Harada uveitis. Invest Ophthalmol Vis Sci 46: pp. 2465-2471
  39. Nomura, S, Matsuzaki, T, Ozaki, Y, Yamaoka, M, Yoshimura, C, Katsura, K, Xie, GL, Kagawa, H, Ishida, T, Fukuhara, S (1998) Clinical significance of HLA-DRB1*0410 in Japanese patients with idiopathic thrombocytopenic purpura. Blood 91: pp. 3616-3622
  40. Alaez, C, Flores, AH, Concha del Rio, LE, Munguia, A, Rodriguez, A, Garcia, D, Arellanes, L, Gorodezky, C (2011) Major histocompatibility complex and strong human leukocyte antigen-DRB1 and gender association with Vogt-Koyanagi-Harada syndrome in Mexican Mestizos. Hum Immunol 72: pp. 1198-1203
  41. Tiercy, JM, Rathinam, SR, Gex-Fabry, M, Baglivo, E (2010) A shared HLA-DRB1 epitope in the DR beta first domain is associated with Vogt-Koyanagi-Harada syndrome in Indian patients. Mol Vis 16: pp. 353-358
  42. Jaini, R, Kaur, G, Mehra, NK (2002) Heterogeneity of HLA-DRB1*04 and its associated haplotypes in the North Indian population. Hum Immunol 63: pp. 24-29
  43. Gupta, A, Kamal, S, Gupta, V, Bambery, P, Kaura, B (2007) HLA typing in Vogt-Koyanagi-Harada syndrome in North Indian patients. Ocul Immunol Inflamm 15: pp. 89-97
  44. Perkins, D, Wang, Z, Donovan, C, He, H, Mark, D, Guan, G, Wang, Y, Walunas, T, Bluestone, J, Listman, J, Finn, PW (1996) Regulation of CTLA-4 expression during T cell activation. J Immunol 156: pp. 4154-4159
  45. Ueda, H, Howson, JM, Esposito, L, Heward, J, Snook, H, Chamberlain, G, Rainbow, DB, Hunter, KM, Smith, AN, Genova, G, Herr, MH, Dahlman, I, Payne, F, Smyth, D, Lowe, C, Twells, RC, Howlett, S, Healy, B, Nutland, S, Rance, HE, Everett, V, Smink, LJ, Lam, AC, Cordell, HJ, Walker, NM, Bordin, C, Hulme, J, Motzo, C, Cucca, F, Hess, JF (2003) Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423: pp. 506-511
  46. Harbo, HF, Celius, EG, Vartdal, F, Spurkland, A (1999) CTLA4 promoter and exon 1 dimorphisms in multiple sclerosis. Tissue Antigens 53: pp. 106-110
  47. Hudson, LL, Rocca, K, Song, YW, Pandey, JP (2002) CTLA-4 gene polymorphisms in systemic lupus erythematosus: a highly significant association with a determinant in the promoter region. Hum Genet 111: pp. 452-455
  48. Gonzalez-Escribano, MF, Rodriguez, R, Valenzuela, A, Garcia, A, Garcia-Lozano, JR, Nunez-Roldan, A (1999) CTLA4 polymorphisms in Spanish patients with rheumatoid arthritis. Tissue Antigens 53: pp. 296-300
  49. Lei, C, Dongqing, Z, Yeqing, S, Oaks, MK, Lishan, C, Jianzhong, J, Jie, Q, Fang, D, Ningli, L, Xinghai, H, Daming, R (2005) Association of the CTLA-4 gene with rheumatoid arthritis in Chinese Han population. Eur J Hum Genet 13: pp. 823-828
  50. Deng, L, Zhou, H, Yang, J, Xiao, J, Wang, B, Wang, L, Ou, X, Feng, Y (2013) CTLA-4 gene polymorphisms and susceptibility to chronic obstructive pulmonary disease. Int J Clin Exp Pathol 6: pp. 2548-2553
  51. Knight, AK, Serrano, D, Tomer, Y, Cunningham-Rundles, C (2007) CTLA-4 gene exon-1 +49 A/G polymorphism: lack of association with autoimmune disease in patients with common variable immune deficiency. J Clin Immunol 27: pp. 95-100
  52. Yanagawa, T, Maruyama, T, Gomi, K, Taniyama, M, Kasuga, A, Ozawa, Y, Terauchi, M, Hirose, H, Maruyama, H, Saruta, T (1999) Lack of association between CTLA-4 gene polymorphism and IDDM in Japanese subjects. Autoimmunity 29: pp. 53-56
  53. Du, L, Yang, P, Hou, S, Lin, X, Zhou, H, Huang, X, Wang, L, Kijlstra, A (2008) Association of the CTLA-4 gene with Vogt-Koyanagi-Harada syndrome. Clin Immunol 127: pp. 43-48
  54. Jha, P, Sohn, JH, Xu, Q, Nishihori, H, Wang, Y, Nishihori, S, Manickam, B, Kaplan, HJ, Bora, PS, Bora, NS (2006) The complement system plays a critical role in the development of experimental autoimmune anterior uveitis. Invest Ophthalmol Vis Sci 47: pp. 1030-1038
  55. Manickam, B, Jha, P, Matta, B, Liu, J, Bora, PS, Bora, NS (2011) Inhibition of complement alternative pathway suppresses experimental autoimmune anterior uveitis by modulating T cell responses. J Biol Chem 286: pp. 8472-8480
  56. Yang, MM, Lai, TY, Tam, PO, Chiang, SW, Chan, CK, Luk, FO, Ng, TK, Pang, CP (2011) CFH 184G as a genetic risk marker for anterior uveitis in Chinese females. Mol Vis 17: pp. 2655-2664
  57. Yang, MM, Lai, TY, Tam, PO, Chiang, SW, Chan, CK, Luk, FO, Ng, TK, Pang, CP (2012) Complement factor H and interleukin gene polymorphisms in patients with non-infectious intermediate and posterior uveitis. Mol Vis 18: pp. 1865-1872
  58. Arocker-Mettinger, E, Asenbauer, T, Ulbrich, S, Grabner, G (1990) Serum interleukin 2-receptor levels in uveitis. Curr Eye Res 9: pp. 25-29
  59. Lacomba, MS, Martin, CM, Chamond, RR, Galera, JM, Omar, M, Estevez, EC (2000) Aqueous and serum interferon gamma, interleukin (IL) 2, IL-4, and IL-10 in patients with uveitis. Arch Ophthalmol 118: pp. 768-772
  60. Liu, L, Xu, Y, Wang, J, Li, H (2009) Upregulated IL-21 and IL-21 receptor expression is involved in experimental autoimmune uveitis (EAU). Mol Vis 15: pp. 2938-2944
  61. Hamzaoui, K, Hamza, M, Ayed, K (1990) Production of TNF-alpha and IL-1 in active Behcet's disease. J Rheumatol 17: pp. 1428-1429
  62. Charteris, DG, Lightman, SL (1994) Comparison of the expression of interferon gamma, IL2, IL4, and lymphotoxin mRNA in experimental autoimmune uveoretinitis. Br J Ophthalmol 78: pp. 786-790
  63. Cordeiro, CA, Moreira, PR, Costa, GC, Dutra, WO, Campos, WR, Orefice, F, Teixeira, AL (2008) Interleukin-1 gene polymorphisms and toxoplasmic retinochoroiditis. Mol Vis 14: pp. 1845-1849
  64. Trinchieri, G (1993) Interleukin-12 and its role in the generation of TH1 cells. Immunol Today 14: pp. 335-338
  65. Frassanito, MA, Dammacco, R, Cafforio, P, Dammacco, F (1999) Th1 polarization of the immune response in Behcet's disease: a putative pathogenetic role of interleukin-12. Arthritis Rheum 42: pp. 1967-1974
  66. Yanagihori, H, Oyama, N, Nakamura, K, Mizuki, N, Oguma, K, Kaneko, F (2006) Role of IL-12B promoter polymorphism in Adamantiades-Behcet's disease susceptibility: an involvement of Th1 immunoreactivity against Streptococcus sanguinis antigen. J Invest Dermatol 126: pp. 1534-1540
  67. Li, X, Bai, L, Fang, J, Hou, S, Zhou, Q, Yu, H, Kijlstra, A, Yang, P (2014) Genetic variations of IL-12B, IL-12Rbeta1, IL-12Rbeta2 in Behcet's disease and VKH syndrome. PLoS One 9: pp. 98373
  68. Chi, W, Yang, P, Li, B, Wu, C, Jin, H, Zhu, X, Chen, L, Zhou, H, Huang, X, Kijlstra, A (2007) IL-23 promotes CD4+ T cells to produce IL-17 in Vogt-Koyanagi-Harada disease. J Allergy Clin Immunol 119: pp. 1218-1224
  69. Shu, Q, Yang, P, Hou, S, Li, F, Chen, Y, Du, L, Jiang, Z (2010) Interleukin-17 gene polymorphism is associated with Vogt-Koyanagi-Harada syndrome but not with Behcet's disease in a Chinese Han population. Hum Immunol 71: pp. 988-991
  70. Cua, DJ, Sherlock, J, Chen, Y, Murphy, CA, Joyce, B, Seymour, B, Lucian, L, To, W, Kwan, S, Churakova, T, Zurawski, S, Wiekowski, M, Lira, SA, Gorman, D, Kastelein, RA, Sedgwick, JD (2003) Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421: pp. 744-748
  71. Murphy, CA, Langrish, CL, Chen, Y, Blumenschein, W, McClanahan, T, Kastelein, RA, Sedgwick, JD, Cua, DJ (2003) Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med 198: pp. 1951-1957
  72. Langrish, CL, Chen, Y, Blumenschein, WM, Mattson, J, Basham, B, Sedgwick, JD, McClanahan, T, Kastelein, RA, Cua, DJ (2005) IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201: pp. 233-240
  73. Jiang, Z, Yang, P, Hou, S, Li, F, Zhou, H (2010) Polymorphisms of IL23R and Vogt-Koyanagi-Harada syndrome in a Chinese Han population. Hum Immunol 71: pp. 414-417
  74. Amadi-Obi, A, Yu, CR, Liu, X, Mahdi, RM, Clarke, GL, Nussenblatt, RB, Gery, I, Lee, YS, Egwuagu, CE (2007) TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat Med 13: pp. 711-718
  75. Cua, DJ, Kastelein, RA (2006) TGF-beta, a 'double agent' in the immune pathology war. Nat Immunol 7: pp. 557-559
  76. Weaver, CT, Harrington, LE, Mangan, PR, Gavrieli, M, Murphy, KM (2006) Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 24: pp. 677-688
  77. Parham, P (2005) Immunogenetics of killer cell immunoglobulin-like receptors. Mol Immunol 42: pp. 459-462
  78. Boyton, RJ, Altmann, DM (2007) Natural killer cells, killer immunoglobulin-like receptors and human leucocyte antigen class I in disease. Clin Exp Immunol 149: pp. 1-8
  79. Sheereen, A, Gaafar, A, Iqneibi, A, Eldali, A, Tabbara, KF, Adra, C, Al-Hussein, K (2011) A study of KIR genes and HLA-C in Vogt-Koyanagi-Harada disease in Saudi Arabia. Mol Vis 17: pp. 3523-3528
  80. Levinson, RD, Okada, AA, Ashouri, E, Keino, H, Rajalingam, R (2010) Killer cell immunoglobulin-like receptor gene-cluster 3DS1-2DL5-2DS1-2DS5 predisposes susceptibility to Vogt-Koyanagi-Harada syndrome in Japanese individuals. Hum Immunol 71: pp. 192-194
  81. Ishida, Y, Agata, Y, Shibahara, K, Honjo, T (1992) Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J 11: pp. 3887-3895
  82. Rui, Y, Honjo, T, Chikuma, S (2013) Programmed cell death 1 inhibits inflammatory helper T-cell development through controlling the innate immune response. Proc Natl Acad Sci USA 110: pp. 16073-16078
  83. Newby, PR, Roberts-Davies, EL, Brand, OJ, Heward, JM, Franklyn, JA, Gough, SC, Simmonds, MJ (2007) Tag SNP screening of the PDCD1 gene for association with Graves' disease. Clin Endocrinol (Oxf) 67: pp. 125-128
  84. Nielsen, C, Hansen, D, Husby, S, Jacobsen, BB, Lillevang, ST (2003) Association of a putative regulatory polymorphism in the PD-1 gene with susceptibility to type 1 diabetes. Tissue Antigens 62: pp. 492-497
  85. Lee, SH, Lee, YA, Woo, DH, Song, R, Park, EK, Ryu, MH, Kim, YH, Kim, KS, Hong, SJ, Yoo, MC, Yang, HI (2006) Association of the programmed cell death 1 (PDCD1) gene polymorphism with ankylosing spondylitis in the Korean population. Arthritis Res Ther 8: pp. R163
  86. Kong, EK, Prokunina-Olsson, L, Wong, WH, Lau, CS, Chan, TM, Alarcon-Riquelme, M, Lau, YL (2005) A new haplotype of PDCD1 is associated with rheumatoid arthritis in Hong Kong Chinese. Arthritis Rheum 52: pp. 1058-1062
  87. Liu, C, Jiang, J, Gao, L, Hu, X, Wang, F, Shen, Y, Yu, G, Zhao, Z, Zhang, X (2014) A promoter region polymorphism in PDCD-1 gene is associated with risk of rheumatoid arthritis in the Han Chinese population of southeastern China. Int J Genomics 2014: pp. 247637
  88. Prokunina, L, Castillejo-Lopez, C, Oberg, F, Gunnarsson, I, Berg, L, Magnusson, V, Brookes, AJ, Tentler, D, Kristjansdottir, H, Grondal, G, Bolstad, AI, Svenungsson, E, Lundberg, I, Sturfelt, G, Jonssen, A, Truedsson, L, Lima, G, Alcocer-Varela, J, Jonsson, R, Gyllensten, UB, Harley, JB, Alarcon-Segovia, D, Steinsson, K, Alarcon-Riquelme, ME (2002) A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat Genet 32: pp. 666-669
  89. Ferreiros-Vidal, I, Gomez-Reino, JJ, Barros, F, Carracedo, A, Carreira, P, Gonzalez-Escribano, F, Liz, M, Martin, J, Ordi, J, Vicario, JL, Gonzalez, A (2004) Association of PDCD1 with susceptibility to systemic lupus erythematosus: evidence of population-specific effects. Arthritis Rheum 50: pp. 2590-2597
  90. Velazquez-Cruz, R, Orozco, L, Espinosa-Rosales, F, Carreno-Manjarrez, R, Solis-Vallejo, E, Lopez-Lara, ND, Ruiz-Lopez, IK, Rodriguez-Lozano, AL, Estrada-Gil, JK, Jimenez-Sanchez, G, Baca, V (2007) Association of PDCD1 polymorphisms with childhood-onset systemic lupus erythematosus. Eur J Hum Genet 15: pp. 336-341
  91. Thorburn, CM, Prokunina-Olsson, L, Sterba, KA, Lum, RF, Seldin, MF, Alarcon-Riquelme, ME, Criswell, LA (2007) Association of PDCD1 genetic variation with risk and clinical manifestations of systemic lupus erythematosus in a multiethnic cohort. Genes Immun 8: pp. 279-287
  92. Kroner, A, Mehling, M, Hemmer, B, Rieckmann, P, Toyka, KV, Maurer, M, Wiendl, H (2005) A PD-1 polymorphism is associated with disease progression in multiple sclerosis. Ann Neurol 58: pp. 50-57
  93. Abelson, AK, Johansson, CM, Kozyrev, SV, Kristjansdottir, H, Gunnarsson, I, Svenungsson, E, Jonsen, A, Lima, G, Scherbarth, HR, Gamron, S, Allievi, A, Palatnik, SA, Alvarellos, A, Paira, S, Graf, C, Guilleron, C, Catoggio, LJ, Prigione, C, Battagliotti, CG, Berbotto, GA, Garcia, MA, Perandones, CE, Truedsson, L, Steinsson, K, Sturfelt, G, Pons-Estel, B, Alarcon-Riquelme, ME (2007) No evidence of association between genetic variants of the PDCD1 ligands and SLE. Genes Immun 8: pp. 69-74
  94. Lin, SC, Yen, JH, Tsai, JJ, Tsai, WC, Ou, TT, Liu, HW, Chen, CJ (2004) Association of a programmed death 1 gene polymorphism with the development of rheumatoid arthritis, but not systemic lupus erythematosus. Arthritis Rheum 50: pp. 770-775
  95. Iwamoto, T, Ikari, K, Inoue, E, Toyama, Y, Hara, M, Yamanaka, H, Tomatsu, T, Momohara, S, Kamatani, N (2007) Failure to confirm association between PDCD1 polymorphisms and rheumatoid arthritis in a Japanese population. J Hum Genet 52: pp. 557-560
  96. Asad, S, Nikamo, P, Torn, C, Landin-Olsson, M, Lernmark, A, Alarcon-Riquelme, M, Kockum, I (2007) No evidence of association of the PDCD1 gene with type 1 diabetes. Diabet Med 24: pp. 1473-1477
  97. Jiao, Q, Liu, C, Yang, Z, Ding, Q, Wang, M, Li, M, Zhu, T, Qian, H, Li, W, Tu, N, Fang, F, Ye, L, Zhao, Z, Qian, Q (2014) Upregulated PD-1 expression is associated with the development of systemic lupus erythematosus, but not the PD-1.1 allele of the PDCD1 gene. Int J Genomics 2014: pp. 950903
  98. Meng, Q, Liu, X, Yang, P, Hou, S, Du, L, Zhou, H, Kijlstra, A (2009) PDCD1 genes may protect against extraocular manifestations in Chinese Han patients with Vogt-Koyanagi-Harada syndrome. Mol Vis 15: pp. 386-392
  99. Bottini, N, Peterson, EJ (2014) Tyrosine phosphatase PTPN22: multifunctional regulator of immune signaling, development, and disease. Annu Rev Immunol 32: pp. 83-119
  100. Bottini, N, Musumeci, L, Alonso, A, Rahmouni, S, Nika, K, Rostamkhani, M, MacMurray, J, Meloni, GF, Lucarelli, P, Pellecchia, M, Eisenbarth, GS, Comings, D, Mustelin, T (2004) A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 36: pp. 337-338
  101. Criswell, LA, Pfeiffer, KA, Lum, RF, Gonzales, B, Novitzke, J, Kern, M, Moser, KL, Begovich, AB, Carlton, VE, Li, W, Lee, AT, Ortmann, W, Behrens, TW, Gregersen, PK (2005) Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes. Am J Hum Genet 76: pp. 561-571
  102. Begovich, AB, Carlton, VE, Honigberg, LA, Schrodi, SJ, Chokkalingam, AP, Alexander, HC, Ardlie, KG, Huang, Q, Smith, AM, Spoerke, JM, Conn, MT, Chang, M, Chang, SY, Saiki, RK, Catanese, JJ, Leong, DU, Garcia, VE, McAllister, LB, Jeffery, DA, Lee, AT, Batliwalla, F, Remmers, E, Criswell, LA, Seldin, MF, Kastner, DL, Amos, CI, Sninsky, JJ, Gregersen, PK (2004) A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 75: pp. 330-337
  103. Michou, L, Lasbleiz, S, Rat, AC, Migliorini, P, Balsa, A, Westhovens, R, Barrera, P, Alves, H, Pierlot, C, Glikmans, E, Garnier, S, Dausset, J, Vaz, C, Fernandes, M, Petit-Teixeira, E, Lemaire, I, Pascual-Salcedo, D, Bombardieri, S, Dequeker, J, Radstake, TR, Riel, P, Putte, L, Lopes-Vaz, A, Prum, B, Bardin, T, Dieude, P, Cornelis, F (2007) Linkage proof for PTPN22, a rheumatoid arthritis susceptibility gene and a human autoimmunity gene. Proc Natl Acad Sci USA 104: pp. 1649-1654
  104. Ichimura, M, Kaku, H, Fukutani, T, Koga, H, Mukai, T, Miyake, I, Yamada, K, Koda, Y, Hiromatsu, Y (2008) Associations of protein tyrosine phosphatase nonreceptor 22 (PTPN22) gene polymorphisms with susceptibility to Graves' disease in a Japanese population. Thyroid 18: pp. 625-630
  105. Kyogoku, C, Langefeld, CD, Ortmann, WA, Lee, A, Selby, S, Carlton, VE, Chang, M, Ramos, P, Baechler, EC, Batliwalla, FM, Novitzke, J, Williams, AH, Gillett, C, Rodine, P, Graham, RR, Ardlie, KG, Gaffney, PM, Moser, KL, Petri, M, Begovich, AB, Gregersen, PK, Behrens, TW (2004) Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am J Hum Genet 75: pp. 504-507
  106. Horie, Y, Kitaichi, N, Katsuyama, Y, Yoshida, K, Miura, T, Ota, M, Asukata, Y, Inoko, H, Mizuki, N, Ishida, S, Ohno, S (2009) Evaluation of PTPN22 polymorphisms and Vogt-Koyanagi-Harada disease in Japanese patients. Mol Vis 15: pp. 1115-1119
  107. Zhang, Q, Qi, J, Hou, S, Du, L, Yu, H, Cao, Q, Zhou, Y, Liao, D, Kijlstra, A, Yang, P (2014) A functional variant of PTPN22 confers risk for Vogt-Koyanagi-Harada syndrome but not for ankylosing spondylitis. PLoS One 9: pp. e96943
  108. Heilmann, K, Hoffmann, U, Witte, E, Loddenkemper, C, Sina, C, Schreiber, S, Hayford, C, Holzlohner, P, Wolk, K, Tchatchou, E, Moos, V, Zeitz, M, Sabat, R, Gunthert, U, Wittig, BM (2009) Osteopontin as two-sided mediator of intestinal inflammation. J Cell Mol Med 13: pp. 1162-1174
  109. Lund, SA, Giachelli, CM, Scatena, M (2009) The role of osteopontin in inflammatory processes. J Cell Commun Signal 3: pp. 311-322
  110. Chu, M, Yang, P, Hu, R, Hou, S, Li, F, Chen, Y, Kijlstra, A (2011) Elevated serum osteopontin levels and genetic polymorphisms of osteopontin are associated with Vogt-Koyanagi-Harada disease. Invest Ophthalmol Vis Sci 52: pp. 7084-7089
  111. Lee, EG, Boone, DL, Chai, S, Libby, SL, Chien, M, Lodolce, JP, Ma, A (2000) Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. Science 289: pp. 2350-2354
  112. Liu, YC, Penninger, J, Karin, M (2005) Immunity by ubiquitylation: a reversible process of modification. Nat Rev Immunol 5: pp. 941-952
  113. Plenge, RM, Cotsapas, C, Davies, L, Price, AL, Bakker, PI, Maller, J, Pe'er, I, Burtt, NP, Blumenstiel, B, DeFelice, M, Parkin, M, Barry, R, Winslow, W, Healy, C, Graham, RR, Neale, BM, Izmailova, E, Roubenoff, R, Parker, AN, Glass, R, Karlson, EW, Maher, N, Hafler, DA, Lee, DM, Seldin, MF, Remmers, EF, Lee, AT, Padyukov, L, Alfredsson, L, Coblyn, J (2007) Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. Nat Genet 39: pp. 1477-1482
  114. Thomson, W, Barton, A, Ke, X, Eyre, S, Hinks, A, Bowes, J, Donn, R, Symmons, D, Hider, S, Bruce, IN, Wilson, AG, Marinou, I, Morgan, A, Emery, P, Carter, A, Steer, S, Hocking, L, Reid, DM, Wordsworth, P, Harrison, P, Strachan, D, Worthington, J (2007) Rheumatoid arthritis association at 6q23. Nat Genet 39: pp. 1431-1433
  115. Nair, RP, Duffin, KC, Helms, C, Ding, J, Stuart, PE, Goldgar, D, Gudjonsson, JE, Li, Y, Tejasvi, T, Feng, BJ, Ruether, A, Schreiber, S, Weichenthal, M, Gladman, D, Rahman, P, Schrodi, SJ, Prahalad, S, Guthery, SL, Fischer, J, Liao, W, Kwok, PY, Menter, A, Lathrop, GM, Wise, CA, Begovich, AB, Voorhees, JJ, Elder, JT, Krueger, GG, Bowcock, AM, Abecasis, GR (2009) Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet 41: pp. 199-204
  116. Graham, RR, Cotsapas, C, Davies, L, Hackett, R, Lessard, CJ, Leon, JM, Burtt, NP, Guiducci, C, Parkin, M, Gates, C, Plenge, RM, Behrens, TW, Wither, JE, Rioux, JD, Fortin, PR, Graham, DC, Wong, AK, Vyse, TJ, Daly, MJ, Altshuler, D, Moser, KL, Gaffney, PM (2008) Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus. Nat Genet 40: pp. 1059-1061
  117. Adrianto, I, Wen, F, Templeton, A, Wiley, G, King, JB, Lessard, CJ, Bates, JS, Hu, Y, Kelly, JA, Kaufman, KM, Guthridge, JM, Alarcon-Riquelme, ME, Anaya, JM, Bae, SC, Bang, SY, Boackle, SA, Brown, EE, Petri, MA, Gallant, C, Ramsey-Goldman, R, Reveille, JD, Vila, LM, Criswell, LA, Edberg, JC, Freedman, BI, Gregersen, PK, Gilkeson, GS, Jacob, CO, James, JA, Kamen, DL (2011) Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus. Nat Genet 43: pp. 253-258
  118. Li, H, Liu, Q, Hou, S, Du, L, Zhou, Q, Zhou, Y, Kijlstra, A, Yang, P (2013) TNFAIP3 gene polymorphisms in a Chinese Han population with Vogt-Koyanagi-Harada syndrome. PLoS One 8: pp. e59515
  119. Baugh, JA, Bucala, R (2002) Macrophage migration inhibitory factor. Crit Care Med 30: pp. S27-35
  120. Donn, RP, Plant, D, Jury, F, Richards, HL, Worthington, J, Ray, DW, Griffiths, CE (2004) Macrophage migration inhibitory factor gene polymorphism is associated with psoriasis. J Invest Dermatol 123: pp. 484-487
  121. Sanchez, E, Gomez, LM, Lopez-Nevot, MA, Gonzalez-Gay, MA, Sabio, JM, Ortego-Centeno, N, Ramon, E, Anaya, JM, Gonzalez-Escribano, MF, Koeleman, BP, Martin, J (2006) Evidence of association of macrophage migration inhibitory factor gene polymorphisms with systemic lupus erythematosus. Genes Immun 7: pp. 433-436
  122. Nohara, H, Okayama, N, Inoue, N, Koike, Y, Fujimura, K, Suehiro, Y, Hamanaka, Y, Higaki, S, Yanai, H, Yoshida, T, Hibi, T, Okita, K, Hinoda, Y (2004) Association of the -173G/C polymorphism of the macrophage migration inhibitory factor gene with ulcerative colitis. J Gastroenterol 39: pp. 242-246
  123. Donn, R, Alourfi, Z, Zeggini, E, Lamb, R, Jury, F, Lunt, M, Meazza, C, Benedetti, F, Thomson, W, Ray, D (2004) A functional promoter haplotype of macrophage migration inhibitory factor is linked and associated with juvenile idiopathic arthritis. Arthritis Rheum 50: pp. 1604-1610
  124. Berdeli, A, Ozyurek, AR, Ulger, Z, Gurses, D, Levent, E, Salar, K, Gurpinar, AR (2006) Association of macrophage migration inhibitory factor gene -173聽G/C polymorphism with prognosis in Turkish children with juvenile rheumatoid arthritis. Rheumatol Int 26: pp. 726-731
  125. Akcali, A, Pehlivan, S, Pehlivan, M, Sever, T, Neyal, M (2010) Association of macrophage migration inhibitory factor gene promoter polymorphisms with multiple sclerosis in Turkish patients. J Int Med Res 38: pp. 69-77
  126. Kotake, S, Kitaichi, N, Ohno, S (2002) Macrophage migration inhibitory factor in uveitis. Int Ophthalmol Clin 42: pp. 99-103
  127. Kitaichi, N, Kotake, S, Sasamoto, Y, Namba, K, Matsuda, A, Ogasawara, K, Onoe, K, Matsuda, H, Nishihira, J (1999) Prominent increase of macrophage migration inhibitory factor in the sera of patients with uveitis. Invest Ophthalmol Vis Sci 40: pp. 247-250
  128. Zhang, C, Liu, S, Hou, S, Lei, B, Zheng, X, Xiao, X, Kijlstra, A, Yang, P (2013) MIF gene polymorphisms confer susceptibility to Vogt-Koyanagi-Harada syndrome in a Han Chinese population. Invest Ophthalmol Vis Sci 54: pp. 7734-7738
  129. Jimenez-Cervantes, C, Solano, F, Kobayashi, T, Urabe, K, Hearing, VJ, Lozano, JA, Garcia-Borron, JC (1994) A new enzymatic function in the melanogenic pathway. The 5,6-dihydroxyindole-2-carboxylic acid oxidase activity of tyrosinase-related protein-1 (TRP1). J Biol Chem 269: pp. 17993-18000
  130. Sturm, RA, Teasdale, RD, Box, NF (2001) Human pigmentation genes: identification, structure and consequences of polymorphic variation. Gene 277: pp. 49-62
  131. Oetting, WS (2000) The tyrosinase gene and oculocutaneous albinism type 1 (OCA1): a model for understanding the molecular biology of melanin formation. Pigment Cell Res 13: pp. 320-325
  132. Sundaresan, P, Sil, AK, Philp, AR, Randolph, MA, Natchiar, G, Namperumalsamy, P (2004) Genetic analysis of oculocutaneous albinism type 1 (OCA1) in Indian families: two novel frameshift mutations in the TYR Gene. Mol Vis 10: pp. 1005-1010
  133. Chaki, M, Mukhopadhyay, A, Chatterjee, S, Das, M, Samanta, S, Ray, K (2005) Higher prevalence of OCA1 in an ethnic group of eastern India is due to a founder mutation in the tyrosinase gene. Mol Vis 11: pp. 531-534
  134. Horie, Y, Takemoto, Y, Miyazaki, A, Namba, K, Kase, S, Yoshida, K, Ota, M, Hasumi, Y, Inoko, H, Mizuki, N, Ohno, S (2006) Tyrosinase gene family and Vogt-Koyanagi-Harada disease in Japanese patients. Mol Vis 12: pp. 1601-1605
  135. Takase, H, Futagami, Y, Yoshida, T, Kamoi, K, Sugita, S, Imai, Y, Mochizuki, M (2006) Cytokine profile in aqueous humor and sera of patients with infectious or noninfectious uveitis. Invest Ophthalmol Vis Sci 47: pp. 1557-1561
  136. Ohno, S (1981) Immunological aspects of Behcet's and Vogt-Koyanagi-Harada's diseases. Trans Ophthalmol Soc UK 101: pp. 335-341
  137. Horie, Y, Kitaichi, N, Takemoto, Y, Namba, K, Yoshida, K, Hirose, S, Hasumi, Y, Ota, M, Inoko, H, Mizuki, N, Ohno, S (2007) Polymorphism of IFN-gamma gene and Vogt-Koyanagi-Harada disease. Mol Vis 13: pp. 2334-2338
  138. Gregersen, PK (2007) Modern genetics, ancient defenses, and potential therapies. N Engl J Med 356: pp. 1263-1266
  139. Alkhateeb, A, Fain, PR, Thody, A, Bennett, DC, Spritz, RA (2003) Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res 16: pp. 208-214
  140. Laberge, G, Mailloux, CM, Gowan, K, Holland, P, Bennett, DC, Fain, PR, Spritz, RA (2005) Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo. Pigment Cell Res 18: pp. 300-305
  141. Jin, Y, Mailloux, CM, Gowan, K, Riccardi, SL, LaBerge, G, Bennett, DC, Fain, PR, Spritz, RA (2007) NALP1 in vitiligo-associated multiple autoimmune disease. N Engl J Med 356: pp. 1216-1225
  142. Horie, Y, Saito, W, Kitaichi, N, Miura, T, Ishida, S, Ohno, S (2011) Evaluation of NLRP1 gene polymorphisms in Vogt-Koyanagi-Harada disease. Jpn J Ophthalmol 55: pp. 57-61
  143. Kandimalla, ER, Zhu, FG, Bhagat, L, Yu, D, Agrawal, S (2003) Toll-like receptor 9: modulation of recognition and cytokine induction by novel synthetic CpG DNAs. Biochem Soc Trans 31: pp. 654-658
  144. Ito, R, Ota, M, Meguro, A, Katsuyama, Y, Uemoto, R, Nomura, E, Nishide, T, Kitaichi, N, Horie, Y, Namba, K, Ohno, S, Inoko, H, Mizuki, N (2011) Investigation of association between TLR9 gene polymorphisms and VKH in Japanese patients. Ocul Immunol Inflamm 19: pp. 202-205
  145. Mangan, PR, Harrington, LE, O'Quinn, DB, Helms, WS, Bullard, DC, Elson, CO, Hatton, RD, Wahl, SM, Schoeb, TR, Weaver, CT (2006) Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441: pp. 231-234
  146. Manel, N, Unutmaz, D, Littman, DR (2008) The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat Immunol 9: pp. 641-649
  147. O'Garra, A, Stockinger, B, Veldhoen, M (2008) Differentiation of human T(H)-17 cells does require TGF-beta!. Nat Immunol 9: pp. 588-590
  148. Chen, Y, Yang, P, Li, F, Hou, S, Jiang, Z, Shu, Q, Kijlstra, A (2012) Association analysis of TGFBR3 gene with Vogt-Koyanagi-Harada disease and Behcet's disease in the Chinese Han population. Curr Eye Res 37: pp. 312-317
  149. Mathur, AN, Chang, HC, Zisoulis, DG, Stritesky, GL, Yu, Q, O'Malley, JT, Kapur, R, Levy, DE, Kansas, GS, Kaplan, MH (2007) Stat3 and Stat4 direct development of IL-17-secreting Th cells. J Immunol 178: pp. 4901-4907
  150. Hu, K, Hou, S, Li, F, Xiang, Q, Kijlstra, A, Yang, P (2013) JAK1, but not JAK2 and STAT3, confers susceptibility to Vogt-Koyanagi-Harada (VKH) syndrome in a Han Chinese population. Invest Ophthalmol Vis Sci 54: pp. 3360-3365
  151. Quan, C, Ren, YQ, Xiang, LH, Sun, LD, Xu, AE, Gao, XH, Chen, HD, Pu, XM, Wu, RN, Liang, CZ, Li, JB, Gao, TW, Zhang, JZ, Wang, XL, Wang, J, Yang, RY, Liang, L, Yu, JB, Zuo, XB, Zhang, SQ, Zhang, SM, Chen, G, Zheng, XD, Li, P, Zhu, J, Li, YW, Wei, XD, Hong, WS, Ye, Y, Zhang, Y (2010) Genome-wide association study for vitiligo identifies susceptibility loci at 6q27 and the MHC. Nat Genet 42: pp. 614-618
  152. Barrett, JC, Hansoul, S, Nicolae, DL, Cho, JH, Duerr, RH, Rioux, JD, Brant, SR, Silverberg, MS, Taylor, KD, Barmada, MM, Bitton, A, Dassopoulos, T, Datta, LW, Green, T, Griffiths, AM, Kistner, EO, Murtha, MT, Regueiro, MD, Rotter, JI, Schumm, LP, Steinhart, AH, Targan, SR, Xavier, RJ, Libioulle, C, Sandor, C, Lathrop, M, Belaiche, J, Dewit, O, Gut, I, Heath, S (2008) Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 40: pp. 955-962
  153. Anderson, CA, Massey, DC, Barrett, JC, Prescott, NJ, Tremelling, M, Fisher, SA, Gwilliam, R, Jacob, J, Nimmo, ER, Drummond, H, Lees, CW, Onnie, CM, Hanson, C, Blaszczyk, K, Ravindrarajah, R, Hunt, S, Varma, D, Hammond, N, Lewis, G, Attlesey, H, Watkins, N, Ouwehand, W, Strachan, D, McArdle, W, Lewis, CM, Lobo, A, Sanderson, J, Jewell, DP, Deloukas, P, Mansfield, JC (2009) Investigation of Crohn's disease risk loci in ulcerative colitis further defines their molecular relationship. Gastroenterology 136: pp. 523-529.e523
  154. Stahl, EA, Raychaudhuri, S, Remmers, EF, Xie, G, Eyre, S, Thomson, BP, Li, Y, Kurreeman, FA, Zhernakova, A, Hinks, A, Guiducci, C, Chen, R, Alfredsson, L, Amos, CI, Ardlie, KG, Barton, A, Bowes, J, Brouwer, E, Burtt, NP, Catanese, JJ, Coblyn, J, Coenen, MJ, Costenbader, KH, Criswell, LA, Crusius, JB, Cui, J, Bakker, PI, Jager, PL, Ding, B, Emery, P (2010) Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet 42: pp. 508-514
  155. Kochi, Y, Okada, Y, Suzuki, A, Ikari, K, Terao, C, Takahashi, A, Yamazaki, K, Hosono, N, Myouzen, K, Tsunoda, T, Kamatani, N, Furuichi, T, Ikegawa, S, Ohmura, K, Mimori, T, Matsuda, F, Iwamoto, T, Momohara, S, Yamanaka, H, Yamada, R, Kubo, M, Nakamura, Y, Yamamoto, K (2010) A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility. Nat Genet 42: pp. 515-519
  156. Chu, X, Pan, CM, Zhao, SX, Liang, J, Gao, GQ, Zhang, XM, Yuan, GY, Li, CG, Xue, LQ, Shen, M, Liu, W, Xie, F, Yang, SY, Wang, HF, Shi, JY, Sun, WW, Du, WH, Zuo, CL, Shi, JX, Liu, BL, Guo, CC, Zhan, M, Gu, ZH, Zhang, XN, Sun, F, Wang, ZQ, Song, ZY, Zou, CY, Sun, WH, Guo, T (2011) A genome-wide association study identifies two new risk loci for Graves' disease. Nat Genet 43: pp. 897-901
  157. Popovici, C, Zhang, B, Gregoire, MJ, Jonveaux, P, Lafage-Pochitaloff, M, Birnbaum, D, Pebusque, MJ (1999) The t(6;8)(q27;p11) translocation in a stem cell myeloproliferative disorder fuses a novel gene, FOP, to fibroblast growth factor receptor 1. Blood 93: pp. 1381-1389
  158. Guasch, G, Ollendorff, V, Borg, JP, Birnbaum, D, Pebusque, MJ (2001) 8p12 stem cell myeloproliferative disorder: the FOP-fibroblast growth factor receptor 1 fusion protein of the t(6;8) translocation induces cell survival mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt/mTOR pathways. Mol Cell Biol 21: pp. 8129-8142
  159. Yan, X, Habedanck, R, Nigg, EA (2006) A complex of two centrosomal proteins, CAP350 and FOP, cooperates with EB1 in microtubule anchoring. Mol Biol Cell 17: pp. 634-644
  160. Yi, X, Du, L, Hou, S, Li, F, Chen, Y, Kijlstra, A, Yang, P (2013) FGFR1OP tagSNP but not CCR6 polymorphisms are associated with Vogt-Koyanagi-Harada syndrome in Chinese Han. PLoS One 8: pp. e69358
  161. Reich, DE, Cargill, M, Bolk, S, Ireland, J, Sabeti, PC, Richter, DJ, Lavery, T, Kouyoumjian, R, Farhadian, SF, Ward, R, Lander, ES (2001) Linkage disequilibrium in the human genome. Nature 411: pp. 199-204
  
• 刊物主题：Ophthalmology;
• 出版者：Springer Berlin Heidelberg
• ISSN：1869-5760

文摘

Vogt-Koyanagi-Harada (VKH) disease is a systemic autoimmune disorder against melanocytes. Recent studies have identified multiple genetic factors that might be associated with the pathogenesis of VKH disease. We performed an electronic database search of PubMed, MEDLINE, and EMBASE, and all relevant papers published up to 13 June 2014 were reviewed. A total of 1,031 publications including articles relevant to the genetics of VKH disease and the references of these articles were reviewed. The review identified a number of genetic factors which might be involved in the pathogenesis of VKH disease, some of which may alter the clinical course of VKH disease. Genes which might be involved in the pathogenesis of VKH disease included genes expressing HLA, complement factor H, interleukins, cytotoxic T-lymphocyte antigen 4 (CTLA-4), killer cell immunoglobulin-like receptors (KIR), programmed cell death 1 (PDCD1), protein tyrosine phosphatase non-receptor 22 (PTPN22), osteopontin, tumor necrosis factor alpha-induced protein 3 (TNFAIP3), macrophage migration inhibitory factor (MIF), and other immune response genes. Further studies to explore the correlation among different genotypes and phenotypes of VKH disease will be useful to shed light on the pathogenesis of uveitis in VKH disease and may facilitate the development of new treatment modalities of uveitis in VKH disease.